Abstract
Objective Current evidence on whether obesity is associated with MGUS remains inconsistent. This study aims to evaluate the association between objectively measured obesity markers and the risk of developing MGUS, using nationally representative data from the U.S. population.
Method Data came from the third National Health and Nutrition Examination Survey III (1988-1994) and continuous NHANES (1999-2004). Multivariable-adjusted odds ratios (aOR) and 95% confidence intervals (CIs) for the association between the risk of developing MGUS and seven obesity markers—including baseline body mass index (BMI), maximum lifetime BMI, waist circumference (WC), waist-hip ratio (WHR), total body fat, fat-free mass, and body percentage fat—were estimated using logistic regression.
Results In the study cohort, a total of 364 participants tested positive for MGUS, compared to 12,043 participants without MGUS. Multivariate logistic regression analysis indicates that each 1% increase in body fat percentage is associated with a 4% (aOR: 1.04, 95% CI [1.01, 1.07]) higher risk of MGUS. Each 1% increase in body fat percentage is also associated with a 6% (aOR: 1.06, 95% CI [1.02, 1.10]) higher risk of non-IgM MGUS. No statistically significant association was found between MGUS and other obesity markers, including baseline BMI, maximum lifetime BMI, WC, WHR, and fat-free mass.
Conclusion Our findings show that obesity is associated with an increase in the risk of MGUS. However, many obesity markers, including the commonly used BMI, fail to capture this association.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the National Cancer Institute of the National Institutes of Health under Award Numbers U01CA265735.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used ONLY openly available human data that were originally located at:https://www.cdc.gov/nchs/nhanes/index.htm
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
